Manufacturers looking to implement these methods have to offer strong validation info to exhibit their equivalence to pharmacopoeial methods. As these new technologies emerge, the WHO emphasizes the importance of an intensive threat assessment and validation approach. This information is aimed completely at healthcare experts or other pro